06

  • One-and-done COVID-19 drug successful

    A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

  • REACH Initiative to expand equity, diversity

    The Stanford School of Medicine launched the REACH Initiative to boost representation in medicine and reduce health inequities among minority populations.

  • Celiac expert Gary Gray dies at 89

    Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.

  • Race linked to child abuse reports

    Over-reporting of Black children and under-reporting of white children as suspected abuse victims suggests systemic bias from medical providers, Stanford Medicine research shows.

  • ARPA-H director shares agency’s vision

    Renee Wegrzyn, who leads the Advanced Research Projects Agency for Health, discussed the agency’s plan to accelerate better health outcomes for everyone.

  • Fasting causes liver cell division

    Cells in the adult liver were thought to divide rarely. But a study led by Stanford Medicine researchers found intermittent fasting causes rapid cell division.

  • Pain treatment inspired by chickens

    In a mouse study led by Stanford Medicine scientists, a drug made mammalian pain receptors more like those in birds — and more resistant to some forms of pain.

  • Telomere length crucial in muscular dystrophy

    Telomeres shorten in heart muscle cells from people with Duchenne muscular dystrophy. A Stanford Medicine study finds blocking this process improves the health of these cells grown in a dish.

  • Diabetes drug may treat heart disease

    A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.

  • Immune cells become cancer killers

    Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.


2023 ISSUE 1

How social factors make or break us